ECEmily Jane Ciccone

Emily Jane Ciccone

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emily Jane Ciccone has a total of 336 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • ICD ‐10‐ CM ‐Based Algorithms to Identify Bacteremia Incorporating Pathogen‐Specific Codes: A Validation Study

    by Madison G. Ponder, Alan C. Kinlaw, Elizabeth S. Dodds Ashley, Jennifer L. Lund, Emily J. Ciccone, Michele Jonsson Funk

    Purpose: Studying patients with bacteremia in real‐world data often requires using microbiologic data to confirm bacterial growth and species. When microbiologic data are unavailable, pathogen‐specific diagnostic codes may be used to classify the bacteremia type. We developed and validated ICD‐10‐CM‐based algorithms for identifying any bacteremia, Gram‐negative bacteremia, and Enterobacteriaceae bacteremia. Methods: We identified patients ≥ 18 years with a hospitalization ≥ 2 days to any Duke Antimicrobial Stewardship Outreach Network hospital from January 1, 2021 to May 31, 2024. Blood culture results were the reference standard for classifying true cases of bacteremia. We evaluated 15 candidate algorithms developed based on previously published algorithms, in addition to the bacteremia ICD‐10‐CM code (R78.81) and pathogen‐specific ICD‐10‐CM codes. We estimated sensitivity, specificity, positive predictive value (PPV), and negative predictive value with 95% confidence intervals using generalized estimating equations to account for correlated hospitalizations. Results: Among 907 958 hospital admissions (623 556 patients), algorithms with bacteremia and pathogen‐specific codes had high specificity (range: 97.3%–100.0%) and low sensitivity (range: 4.9%–58.1%). Algorithms with bacteremia codes and no pathogen codes were more sensitive (range: 67.4%–68.6%) and less specific (range: 91.1%–91.2%). In subgroup analyses, PPV for any bacteremia was highest among patients alive at discharge, age ≥ 65, and discharged on antibiotics with Gram‐negative coverage (68.9% [65.1%–72.7%]). Conclusions: We developed and internally validated algorithms to identify bacteremia, Gram‐negative bacteremia, and Enterobacteriaceae bacteremia in adult patients. Studies seeking to maximize specificity could consider algorithms that include bacteremia and pathogen‐specific codes, whereas studies seeking to maximize sensitivity could consider algorithms only requiring a bacteremia code.

  • Open Access

    False-positive Malaria Rapid Diagnostic Tests are Prevalent Among Children Under 5 Years of Age in Uganda

    by Caitlin A Cassidy, Bonnie E Shook-Sa, Ross M Boyce, Emily J Ciccone, Emily W Gower, Amber M Young, Jessie K Edwards

    Background: Malaria rapid diagnostic tests (mRDTs) are a cornerstone of malaria testing and treatment efforts globally. However, positive mRDT results can occur after treatment due to antigen persistence, even in the absence of malaria parasites. False-negative mRDTs are well-described, but less is known about the prevalence and consequences of such false-positive results. Methods: We estimated the prevalence of false-positive mRDTs, defined as mRDT(+)/microscopy(−), using data from the 2018–2019 Uganda Malaria Indicator Survey (MIS). Children aged <5 years (under-5s) with paired mRDT and microscopy results were included. We estimated the prevalence of false-positive mRDTs among microscopy(−) children using survey weights. We fit bivariate generalized linear models to estimate the prevalence difference (PD) of false-positive mRDTs for pre-specified covariates. We constructed cross-validated weighted lasso regression models to determine which variables best predict false-positive mRDTs among children with recent fever. Results: The prevalence of false-positive mRDTs was 10.7% (849/6786) and was strongly correlated with region-level transmission intensity. Prevalence was higher among children with recent fever (PD: 17.2%; 95% CI: 13.7%, 20.6%), recent antimalarial use (14.7%; 7.1%, 22.3%), and comorbid anemia (8.1%; 5.9%, 10.3%). Prevalence was lower among those with recent antibiotic use (−17.6%; −22.5%, −12.7%). A model with clinical, environmental, and household variables better predicted false-positive mRDTs (weighted AUC = 0.79) than individual models. Conclusions: False-positive mRDTs are prevalent among under-5s in the 2018–19 Uganda MIS and lead to overestimates of community-level malaria prevalence. These results suggest that false-positive mRDTs may also contribute to misdiagnosis and unnecessary antimalarial use in clinical settings.


  • Open Access

    Antimicrobial changes made for suspected infectious diarrhea after positive gastrointestinal pathogen panel result

    by Natalie A. Mackow, Madison G. Ponder, Samantha R. Eiffert, Banks W. Kooken, Melissa B. Miller, Luther A. Bartelt, Alan C. Kinlaw, Emily J. Ciccone

    Objective: To determine the frequency of antimicrobial management changes in response to positive gastrointestinal pathogen multiplex panel (GIP) results in patients with suspected infectious diarrhea, identify predictors of those changes, and assess their guideline adherence. Design: Single-center, retrospective cohort study Setting: Tertiary referral center, including ambulatory and acute care settings. Patients: Adult and pediatric patients with diarrhea and positive GIP evaluated in emergency department, inpatient, or outpatient settings between January 1 and December 31, 2018, were included. Patients considered immunocompromised due to underlying conditions and/or current/recent immunosuppressive therapies were excluded. Methods: The primary outcome of interest was any change in antimicrobial treatment in response to a positive GIP. The secondary outcome was adherence to pathogen-specific guideline-recommended management. Marginal standardization with logistic regression models was also used to assess predictors of antimicrobial management change. Results: The analysis included 193 patients with diarrhea and a positive GIP. The most frequently detected pathogens were norovirus, Salmonella, and Campylobacter. The median time from test collection to result was 31 hours [Q1, Q3: 24, 52]. Of the 193 patients, 71 (37%) experienced an antimicrobial management change, 61 of whom (86%) were considered guideline-adherent. In adjusted models, empiric antimicrobial treatment and testing in outpatient settings were significantly associated with experiencing an antimicrobial change. Conclusions: Around one-third of patients with a positive GIP test experienced a change in antimicrobials, and most of these changes were guideline-adherent. Most GIP tests ordered during the study period were negative, and most positive tests did not require antimicrobial therapy.

  • Open Access

    “We might have been prescribing antibiotics to clients who do not need them”: a mixed-methods study of knowledge, attitudes, and practices related to antibiotic use for pediatric acute respiratory illness among community health workers in Uganda

    by Emily J. Ciccone, Ana T. Bravo Gutierrez, Grace Nyangoma, Victoria Shelus, Georget Kibaba, Fred Mwebembezi, Emmanuel Baguma, Raquel Reyes, Jonathan J. Juliano, Ross M. Boyce, et al.

    In many resource-constrained settings, community health workers (CHW) often provide the initial care for children under five years of age. As part of integrated community case management (iCCM) programs, CHW frequently diagnose and treat acute respiratory illness (ARI), a leading cause of pediatric mortality and indication for antibiotic use globally. Yet knowledge and perceptions of antibiotic prescribing for ARI among CHW are not well-studied. The goal of this study was to assess knowledge, attitudes, and practices related to antibiotics among CHW implementing a stepped-wedge trial of an enhanced iCCM algorithm for children with ARI in rural Uganda to inform future antimicrobial stewardship strategies. We conducted a nested mixed methods study with a convergent parallel design, administering surveys before and after the stepped wedge trial and individual semi-structured interviews at study end. We employed descriptive statistics, Wilcoxan rank sum tests, and thematic content analysis methods. A total of 63 of 67 (94.0%) CHW completed both baseline and follow-up surveys, and 15 CHW were interviewed. The median age of the full cohort was 40 (IQR: 35–47) years with 9.5 years of CHW experience (IQR: 4.0–14.0 years). Almost all CHW (95.2%) identified amoxicillin as an antibiotic at baseline, and most associated antibiotics with treating bacterial diseases (baseline: 82.5%, follow-up: 93.7%, p = 0.05). Most perceived antibiotics as harmful to patients when prescribed unnecessarily. At follow-up, more CHW disagreed that antibiotics should be prescribed when in doubt. They welcomed additional education about antimicrobial resistance and diagnostic tools to advance antimicrobial stewardship (AMS). CHW were overall familiar with antibiotics and their potential harms. They were eager to gain knowledge regarding AMS and AMR and share it with their communities. CHW represent an underutilized resource for AMS interventions and should be included in their design and implementation.


  • Open Access

    The association between depressive symptoms and antibody response following SARS-CoV-2 vaccination among central North Carolina residents

    by Caitlin A. Cassidy, Jessie K. Edwards, Annika K. Gunderson, Haley Abernathy, Haley E. Garrett, Elise King, Cherese N. Beatty Parker, Anne P. Starling, Emily J. Ciccone, Ross M. Boyce, et al.

    A large body of research suggests that stress can affect how the immune system responds to vaccines. The impact of mental health disorders on humoral antibody response following immunization is not well understood, particularly for the COVID-19 vaccines. Leveraging a population-based longitudinal cohort assessing SARS-CoV-2 incidence in central North Carolina, we sought to investigate the relationship between mental health and immune response to vaccination. The 106 participants responded to biweekly surveys and contributed monthly serum samples that underwent SARS-CoV-2 spike antibody testing via enzyme-linked immunosorbent assay (ELISA). Utilizing weighted generalized linear models, we measured the association between depressive symptoms as recorded on the CESD-20 and quantitative antibody levels after COVID-19. Overall, we found modest differences in post-vaccination IgG between participants with depression and those without. Individuals with depressive symptoms had smaller initial antibody responses after vaccination (mean difference = -3.55, 95% CI = (-12.01, 4.90)). These results suggest that mental health disorders may affect immune response to vaccination.

  • Open Access

    Pervasive Intestinal Carriage with Multiple Species of Extended Spectrum Cephalosporin-Resistant Enterobacterales in Children Admitted for Severe Acute Malnutrition at a Tertiary Hospital in Malawi

    by Thomas Holowka, Arrington Ashford, Trieu-Vi Khuu, Alisher Bimagambetov, Courtney N. Dial, Alexander Kondwani, Amazing-Grace Tepeka, Kevin Alby, Jonathan J. Juliano, Anthony J. Garcia-Prats, et al.

    Using culture-based screening of stool specimens, 80.3% of 188 children hospitalized for severe acute malnutrition in Malawi carried extended spectrum cephalosporin resistant Enterobacterales (ESCR-E) at admission. 38.3% of children were colonized with multiple ESCR-E species. Over half of the colonized children did not have recent antibiotic exposure or prior hospitalization.

  • Infections and Antibiotic Resistance in Malawian Children Under Five-Years Old Hospitalized With Severe Acute Malnutrition

    by Bryan J Vonasek, Mwawi Nyirongo, Alexander Kondwani, Tiwonge Kamvaunamwali, Doris Ng’oMa, Emily J Ciccone, James Kaphatika, Amazing-Grace Tepeka, Mercy Kumwenda, Jens Eickhoff, et al.

    This prospective cohort study from Malawi updates our understanding of the burden of bacterial infections and drug resistance in children 1/3 of the bacteria isolated.


  • Open Access

    Point-of-care C-reactive protein measurement by community health workers safely reduces antimicrobial use among children with respiratory illness in rural Uganda: A stepped wedge cluster randomized trial

    by Emily J Ciccone, Di Hu, John S Preisser, Caitlin A Cassidy, Lydiah Kabugho, Baguma Emmanuel, Georget Kibaba, Fred Mwebembezi, Jonathan J Juliano, Edgar M Mulogo, et al.

    Background: Acute respiratory illness (ARI) is one of the most common reasons children receive antibiotic treatment. Measurement of C-reaction protein (CRP) has been shown to reduce unnecessary antibiotic use among children with ARI in a range of clinical settings. In many resource-constrained contexts, patients seek care outside the formal health sector, often from lay community health workers (CHW). This study’s objective was to determine the impact of CRP measurement on antibiotic use among children presenting with febrile ARI to CHW in Uganda. Methods and findings: We conducted a cross-sectional, stepped wedge cluster randomized trial in 15 villages in Bugoye subcounty comparing a clinical algorithm that included CRP measurement by CHW to guide antibiotic treatment (STAR Sick Child Job Aid [SCJA]; intervention condition) with the Integrated Community Care Management (iCCM) SCJA currently in use by CHW in the region (control condition). Villages were stratified into 3 strata by altitude, distance to the clinic, and size; in each stratum, the 5 villages were randomly assigned to one of 5 treatment sequences. Children aged 2 months to 5 years presenting to CHW with fever and cough were eligible. CHW conducted follow-up assessments 7 days after the initial visit. Our primary outcome was the proportion of children who were given or prescribed an antibiotic at the initial visit. Our secondary outcomes were (1) persistent fever on day 7; (2) development of prespecified danger signs; (3) unexpected visits to the CHW; (4) hospitalizations; (5) deaths; (6) lack of perceived improvement per the child’s caregiver on day 7; and (7) clinical failure, a composite outcome of persistence of fever on day 7, development of danger signs, hospitalization, or death. The 65 participating CHW enrolled 1,280 children, 1,220 (95.3%) of whom had sufficient data. Approximately 48% (587/1,220) and 52% (633/1,220) were enrolled during control (iCCM SCJA) and intervention periods (STAR SCJA), respectively. The observed percentage of children who were given or prescribed antibiotics at the initial visit was 91.8% (539/587) in the control periods as compared to 70.8% (448/633) during the intervention periods (adjusted prevalence difference −24.6%, 95% CI: −36.1%, −13.1%). The odds of antibiotic prescription by the CHW were over 80% lower in the intervention as compared to the control periods (OR 0.18, 95% CI: 0.06, 0.49). The frequency of clinical failure (iCCM SCJA 3.9% (23/585) v. STAR SCJA 1.8% (11/630); OR 0.41, 95% CI: 0.09, 1.83) and lack of perceived improvement by the caregiver (iCCM SCJA 2.1% (12/584) v. STAR SCJA 3.5% (22/627); OR 1.49, 95% CI: 0.37, 6.52) was similar. There were no unexpected visits or deaths in either group within the follow-up period. Conclusions: Incorporating CRP measurement into iCCM algorithms for evaluation of children with febrile ARI by CHW in rural Uganda decreased antibiotic use. There is evidence that this decrease was not associated with worse clinical outcomes, although the number of adverse events was low. These findings support expanded access to simple, point-of-care diagnostics to improve antibiotic stewardship in rural, resource-constrained settings where individuals with limited medical training provide a substantial proportion of care. Trial registration: ClinicalTrials.gov NCT05294510. The study was reviewed and approved by the University of North Carolina Institutional Review Board (#18–2803), Mbarara University of Science and Technology Research Ethics Committee (14/03-19), and Uganda National Council on Science and Technology (HS 2631).


  • Impact of Sulfadoxine-Pyrimethamine and Dihydroartemisinin-Piperaquine as Intermittent Preventive Treatment in Pregnancy on Stool Antimicrobial Resistance Gene Abundance

    by Kofi B. Opoku, Kathleen Tompkins, Andreea Waltmann, Emily J. Ciccone, Luther Bartlelt, Tessa Andermann, Jobiba Chinkhumba, Don P. Mathanga, Julie R. Gutman, Jonathan J. Juliano

    : Increasing antimicrobial resistance (AMR) is a global public health emergency. Although chemoprevention has improved malaria-related pregnancy outcomes, the downstream effects on AMR have not been characterized. We compared the abundance of 10 AMR genes in stool samples from pregnant women receiving sulfadoxine-pyrimethamine (SP) as intermittent preventive treatment against malaria in pregnancy (IPTp) to that in samples from women receiving dihydroartemisinin-piperaquine (DP) for IPTp. All participants had at least one AMR gene at baseline. Mean quantities of the antifolate gene dfrA17 were increased after two or more doses of SP (mean difference = 1.6, 95% CI: 0.4–2.7, P = 0.008). Antimicrobial resistance gene abundance tended to increase from baseline in SP recipients compared with a downward trend in the DP group. Overall, IPTp-SP had minimal effects on the abundance of antifolate resistance genes (except for dfrA17), potentially owing to a high starting prevalence. However, the trend toward increasing AMR in SP recipients warrants further studies.


  • Open Access

    Point-of-care C-reactive protein measurement by community health workers safely reduces antimicrobial use among children with respiratory illness: results from a stepped wedge cluster-randomized trial in rural Uganda

    by Emily J. Ciccone, Di Hu, John S. Preisser, Caitlin A. Cassidy, Lydia Kabugho, Baguma Emmanuel, Georget Kibaba, Fred Mwebembezi, Jonathan J. Juliano, Edgar M. Mulogo, et al.

    Background: Acute respiratory illness (ARI) is one of the most common reasons children receive antibiotic treatment. Measurement of C-reaction protein (CRP) to identify children at high risk for bacterial infection has been shown to reduce unnecessary antibiotic use among children with ARI in a range of clinical settings. Yet in many resource-constrained contexts, patients seek care outside the formal health sector, often from lay community health workers (CHW). The objective of this study was to determine the impact of CRP measurement on antibiotic use among children under 5 years of age presenting with febrile ARI to CHW in rural western Uganda. Methods and Findings: We conducted a stepped wedge cluster randomized trial comparing a clinical algorithm that included CRP measurement by CHW to guide antibiotic treatment decisions (STAR Sick Child Job Aid [SCJA]) with the Integrated Community Care Management (iCCM) SCJA currently in use by CHW in the region. Children under 5 years presenting to CHW in 15 villages in Bugoye sub-county with fever and cough were eligible. The CHW conducted follow-up assessments 7 days after the initial visit. Our primary outcome was the proportion of children who were given or prescribed an antibiotic at the initial visit. Our secondary outcomes were (1) persistent fever on Day 7, (2) development of pre-specified danger signs, (3) unexpected visits to the CHW, (4) hospitalizations, (5) deaths, (6) lack of perceived improvement per the child’s caregiver on Day 7, and (7) clinical failure, which was a composite outcome of persistence of fever on Day 7, development of danger signs, hospitalization, or death. The 65 participating CHW enrolled 1,280 children, 1,220 (95.3%) of whom had sufficient data to be included in this analysis; 48% (587/1,220) and 52% (633/1,220) were enrolled during control (iCCM SCJA) and intervention periods (STAR SCJA), respectively. The observed percentage of children who were given or prescribed antibiotics at the initial visit was 91.8% (539/587) in the control periods as compared to 70.8% (448/633) during the intervention periods (prevalence difference -21.0%; 95% CI: (-30.4%, - 11.7%). The odds of antibiotic prescription by the CHW were over 80% lower in the intervention as compared to the control periods (OR 0.18, 95% CI (0.07-0.45)). There was no difference in frequency of clinical failure or lack of perceived improvement by the caregiver between groups. There were no unexpected visits to the CHW or deaths in either group. Conclusions: Incorporating CRP measurement into iCCM algorithms for evaluation of children with febrile ARI by CHW in rural Uganda decreased antibiotic use without negatively affecting clinical outcomes. These findings support expanded access to simple, point-of-care diagnostics to improve antibiotic stewardship in rural, resource-constrained settings where individuals with limited medical training provide a substantial proportion of care.